PGR has virtually no debt, $47m in tax credits, yes that is not a typo and will have revenue of around $300m this FY. EBITDA should come in around $26m, make that EBTDA, all for a market cap of less than $90m.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
